Todd M. Suter

Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist

Francis S. Willard, Jonathan D. Douros, M Gabe et al. · JCI Insight · 2020 · 487 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Decreased Expression Of apM1 in Omental and Subcutaneous Adipose Tissue of HumansWith Type 2 Diabetes

Michael A. Statnick, Lisa S. Beavers, Laura J. Conner et al. · Journal of Diabetes Research · 2000 · 204 citations · Full text

Medicine, Endocrinology, Molecular Biology +17

GH-Releasing Peptide-2 Increases Fat Mass in Mice Lacking NPY: Indication for a Crucial Mediating Role of Hypothalamic Agouti-Related Protein

Matthias H. Tschöp, Michael A. Statnick, Todd M. Suter et al. · Endocrinology · 2002 · 149 citations

Life Sciences, Endocrinology, Physiology +17

Structural determinants of dual incretin receptor agonism by tirzepatide

Bingfa Sun, Francis S. Willard, Dan Feng et al. · Proceedings of the National Academy of Sciences · 2022 · 114 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Antagonism of opioid receptors reduces body fat in obese rats by decreasing food intake and stimulating lipid utilization

Michael A. Statnick, Frank C. Tinsley, Brian J. Eastwood et al. · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · 2003 · 50 citations

Medicine, Nutritional Sciences, Pharmacology +17